# Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management

> **NCT07160829** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 608 (actual)

## Conditions studied

- Atherosclerotic Cardiovascular Disease
- Heart Failure
- Chronic Kidney Disease

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT07160829
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-18
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 608 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07160829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07160829, "Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07160829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*